Alicia M Alcamo1,2, Scott L Weiss1,2, Julie C Fitzgerald1,2, Matthew P Kirschen1,2, Laura L Loftis3, Swee Fong Tang4, Neal J Thomas1,5, Vinay M Nadkarni1, Sholeen T Nett6. 1. Division of Critical Care Medicine, Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, Philadelphia, PA. 2. Department of Anesthesiology and Critical Care, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA. 3. Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX. 4. Pediatric Intensive Care Unit, Specialist Children's Hospital, Department of Paediatrics, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. 5. Division of Pediatric Critical Care Medicine, Department of Pediatrics and Public Health Science, Penn State Hershey Children's Hospital, Penn State College of Medicine, Hershey, PA. 6. Department of Pediatric Critical Care Medicine, Children's Hospital at Dartmouth, Lebanon, NH.
Abstract
OBJECTIVES: To compare outcomes associated with timing-early versus late-of any neurologic dysfunction during pediatric sepsis. DESIGN: Secondary analysis of a cross-sectional point prevalence study. SETTING: A total of 128 PICUs in 26 countries. PATIENTS: Less than 18 years with severe sepsis on 5 separate days (2013-2014). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were categorized as having either no neurologic dysfunction or neurologic dysfunction (i.e., present at or after sepsis recognition), which was defined as Glasgow Coma Scale score less than 5 and/or fixed dilated pupils. Our primary outcome was death or new moderate disability (i.e., Pediatric Overall [or Cerebral] Performance Category score ≥3 and change ≥1 from baseline) at hospital discharge, and 87 of 567 severe sepsis patients (15%) had neurologic dysfunction within 7 days of sepsis recognition (61 at sepsis recognition and 26 after sepsis recognition). Primary site of infection varied based on presence of neurologic dysfunction. Death or new moderate disability occurred in 161 of 480 (34%) without neurologic dysfunction, 45 of 61 (74%) with neurologic dysfunction at sepsis recognition, and 21 of 26 (81%) with neurologic dysfunction after sepsis recognition (p < 0.001 across all groups). On multivariable analysis, in comparison with those without neurologic dysfunction, neurologic dysfunction whether at sepsis recognition or after was associated with increased odds of death or new moderate disability (adjusted odds ratio, 4.9 [95% CI, 2.3-10.1] and 10.7 [95% CI, 3.8-30.5], respectively). We failed to identify a difference between these adjusted odds ratios of death or new moderate disability that would indicate a differential risk of outcome based on timing of neurologic dysfunction (p = 0.20). CONCLUSIONS: In this severe sepsis international cohort, the presence of neurologic dysfunction during sepsis is associated with worse outcomes at hospital discharge. The impact of early versus late onset of neurologic dysfunction in sepsis on outcome remains unknown, and further work is needed to better understand timing of neurologic dysfunction onset in pediatric sepsis.
OBJECTIVES: To compare outcomes associated with timing-early versus late-of any neurologic dysfunction during pediatric sepsis. DESIGN: Secondary analysis of a cross-sectional point prevalence study. SETTING: A total of 128 PICUs in 26 countries. PATIENTS: Less than 18 years with severe sepsis on 5 separate days (2013-2014). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Patients were categorized as having either no neurologic dysfunction or neurologic dysfunction (i.e., present at or after sepsis recognition), which was defined as Glasgow Coma Scale score less than 5 and/or fixed dilated pupils. Our primary outcome was death or new moderate disability (i.e., Pediatric Overall [or Cerebral] Performance Category score ≥3 and change ≥1 from baseline) at hospital discharge, and 87 of 567 severe sepsis patients (15%) had neurologic dysfunction within 7 days of sepsis recognition (61 at sepsis recognition and 26 after sepsis recognition). Primary site of infection varied based on presence of neurologic dysfunction. Death or new moderate disability occurred in 161 of 480 (34%) without neurologic dysfunction, 45 of 61 (74%) with neurologic dysfunction at sepsis recognition, and 21 of 26 (81%) with neurologic dysfunction after sepsis recognition (p < 0.001 across all groups). On multivariable analysis, in comparison with those without neurologic dysfunction, neurologic dysfunction whether at sepsis recognition or after was associated with increased odds of death or new moderate disability (adjusted odds ratio, 4.9 [95% CI, 2.3-10.1] and 10.7 [95% CI, 3.8-30.5], respectively). We failed to identify a difference between these adjusted odds ratios of death or new moderate disability that would indicate a differential risk of outcome based on timing of neurologic dysfunction (p = 0.20). CONCLUSIONS: In this severe sepsis international cohort, the presence of neurologic dysfunction during sepsis is associated with worse outcomes at hospital discharge. The impact of early versus late onset of neurologic dysfunction in sepsis on outcome remains unknown, and further work is needed to better understand timing of neurologic dysfunction onset in pediatric sepsis.
Authors: J A Russell; J Singer; G R Bernard; A Wheeler; W Fulkerson; L Hudson; R Schein; W Summer; P Wright; K R Walley Journal: Crit Care Med Date: 2000-10 Impact factor: 7.598
Authors: Scott L Weiss; Fran Balamuth; Josey Hensley; Julie C Fitzgerald; Jenny Bush; Vinay M Nadkarni; Neal J Thomas; Mark Hall; Jennifer Muszynski Journal: Pediatr Crit Care Med Date: 2017-09 Impact factor: 3.624
Authors: Jean-Francois Dhainaut; Andrew F Shorr; William L Macias; Marin J Kollef; Marcel Levi; Konrad Reinhart; David R Nelson Journal: Crit Care Med Date: 2005-02 Impact factor: 7.598
Authors: Stéphane Leteurtre; Alain Duhamel; Julia Salleron; Bruno Grandbastien; Jacques Lacroix; Francis Leclerc Journal: Crit Care Med Date: 2013-07 Impact factor: 7.598
Authors: Lahn Straney; Archie Clements; Roger C Parslow; Gale Pearson; Frank Shann; Jan Alexander; Anthony Slater Journal: Pediatr Crit Care Med Date: 2013-09 Impact factor: 3.624
Authors: Scott L Weiss; Donglan Zhang; Jenny Bush; Kathryn Graham; Jonathan Starr; Florin Tuluc; Sarah Henrickson; Todd Kilbaugh; Clifford S Deutschman; Deborah Murdock; Francis X McGowan; Lance Becker; Douglas C Wallace Journal: Crit Care Med Date: 2019-10 Impact factor: 7.598